Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Pugh

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Kidney International|December 23, 2011
The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathyJennifer A Hirst, Kathryn S Taylor, Richard J Stevens, et al.
FEBS Letters|July 15, 2004
The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperoninNorma Masson, Rebecca J Appelhoff, Jason R Tuckerman, et al.
The Journal of Biological Chemistry|July 13, 2004
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factorRebecca J Appelhoff, Ya-Min Tian, Raju R Raval, et al.
The Journal of Biological Chemistry|March 7, 2007
Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressorAlexandra Grosfeld, Ineke P Stolze, Matthew E Cockman, et al.
The Journal of Biological Chemistry|November 26, 2002
Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alphaJonathan M Elkins, Kirsty S Hewitson, Luke A McNeill, et al.
The Biochemical Journal|July 9, 2004
Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activityDavid E Lancaster, Luke A McNeill, Michael A McDonough, et al.
Blood|December 3, 2008
Regulation of growth differentiation factor 15 expression by intracellular ironSamira Lakhal, Nick P Talbot, Alexi Crosby, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylasesImre Schlemminger, David R Mole, Luke A McNeill, et al.
Journal of Molecular and Cellular Cardiology|June 13, 2006
HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligationCarsten Willam, Patrick H Maxwell, Lynn Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2002
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesisCarsten Willam, Norma Masson, Ya-Min Tian, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Kidney International|December 23, 2011
The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathyJennifer A Hirst, Kathryn S Taylor, Richard J Stevens, et al.
FEBS Letters|July 15, 2004
The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperoninNorma Masson, Rebecca J Appelhoff, Jason R Tuckerman, et al.
The Journal of Biological Chemistry|July 13, 2004
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factorRebecca J Appelhoff, Ya-Min Tian, Raju R Raval, et al.
The Journal of Biological Chemistry|March 7, 2007
Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressorAlexandra Grosfeld, Ineke P Stolze, Matthew E Cockman, et al.
The Journal of Biological Chemistry|November 26, 2002
Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alphaJonathan M Elkins, Kirsty S Hewitson, Luke A McNeill, et al.
The Biochemical Journal|July 9, 2004
Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activityDavid E Lancaster, Luke A McNeill, Michael A McDonough, et al.
Blood|December 3, 2008
Regulation of growth differentiation factor 15 expression by intracellular ironSamira Lakhal, Nick P Talbot, Alexi Crosby, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylasesImre Schlemminger, David R Mole, Luke A McNeill, et al.
Journal of Molecular and Cellular Cardiology|June 13, 2006
HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligationCarsten Willam, Patrick H Maxwell, Lynn Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2002
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesisCarsten Willam, Norma Masson, Ya-Min Tian, et al.
Pageof 7